Literature DB >> 28987666

A comparative analysis of dual-phase dual-energy CT and FDG-PET/CT for the prediction of histopathological invasiveness of non-small cell lung cancer.

Rintaro Ito1, Shingo Iwano2, Hironori Shimamoto1, Hiroyasu Umakoshi1, Koji Kawaguchi3, Shinji Ito1, Katsuhiko Kato4, Shinji Naganawa1.   

Abstract

PURPOSE: To compare dual-phase dual-energy CT (DE-CT) with FDG-PET/CT for predicting histopathological locoregional invasiveness of non-small cell lung cancers (NSCLCs).
MATERIALS AND METHODS: We selected 63 consecutive patients with NSCLC lesions (37 males, 26 females; age range, 44-85 years; mean age, 69 years) who were evaluated preoperatively by both DE-CT and PET/CT at our institution. Postoperative microscopic invasiveness (lymphatic permeation, vascular invasion, and/or pleural involvement) was reviewed, and we defined locoregionally invasive tumors as those that had at least one positive finding of microscopic invasiveness. DE-CT scanning in the arterial and delayed phases was performed after injection of iodinated contrast media using 140-kVp and 80-kVp tube voltages. Three-dimensional iodine-related attenuation of primary tumors in the arterial and delayed phases was quantified automatically using "syngo Dual Energy Lung Nodules" application software, and the ratio of arterial phase to delayed phase enhancement (A/D ratio) was calculated. The A/D ratio and SUVmax on PET/CT were evaluated with respect to postoperative invasiveness by univariate logistic regression analysis.
RESULTS: The A/D ratio was significantly correlated with lymphatic permeation, vascular invasion, and pleural involvement (p=0.011, p=0.021, and p=0.010, respectively). In contrast, the SUVmax was significantly correlated with pleural involvement (p=0.020) but not with lymphatic permeation or vascular invasion (p=0.088 and p=0.100, respectively). In the subgroup of patients with lesion diameters ≤2cm, the A/D ratio was significantly correlated with locoregional invasiveness (p=0.040), while the SUVmax was not (p=0.121).
CONCLUSION: For the prediction of microscopic invasiveness of NSCLCs, the diagnostic performance of dual-phase DE-CT may be comparable to that of FDG-PET/CT.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dual-energy CT; FDG-PET/CT; Iodine related attenuation; Non-small cell lung cancer; Prognosis

Mesh:

Substances:

Year:  2017        PMID: 28987666     DOI: 10.1016/j.ejrad.2017.08.010

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  6 in total

1.  A comparison study of dual-energy spectral CT and 18F-FDG PET/CT in primary tumors and lymph nodes of lung cancer.

Authors:  Osman Kupik; Yavuz Metin; Gülnihan Eren; Nurgul Orhan Metin; Medeni Arpa
Journal:  Diagn Interv Radiol       Date:  2021-03       Impact factor: 2.630

Review 2.  Extra-abdominal dual-energy CT applications: a comprehensive overview.

Authors:  Giuseppe Cicero; Giorgio Ascenti; Moritz H Albrecht; Alfredo Blandino; Marco Cavallaro; Tommaso D'Angelo; Maria Ludovica Carerj; Thomas J Vogl; Silvio Mazziotti
Journal:  Radiol Med       Date:  2020-01-10       Impact factor: 3.469

Review 3.  The developing role of FDG PET imaging for prognostication and radiotherapy target volume delineation in non-small cell lung cancer.

Authors:  Tom Konert; Jeroen B van de Kamer; Jan-Jakob Sonke; Wouter V Vogel
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

4.  Comparative study of dual energy CT iodine imaging and standardized concentrations before and after chemoradiotherapy for esophageal cancer.

Authors:  Xiaomin Ge; Jingping Yu; Zhongling Wang; Yiqun Xu; Changjie Pan; Lu Jiang; Yanling Yang; Kai Yuan; Wei Liu
Journal:  BMC Cancer       Date:  2018-11-16       Impact factor: 4.430

5.  Iodine-related attenuation in contrast-enhanced dual-energy computed tomography in small-sized solid-type lung cancers is associated with the postoperative prognosis.

Authors:  Shingo Iwano; Shinichiro Kamiya; Rintaro Ito; Shota Nakamura; Shinji Naganawa
Journal:  Cancer Imaging       Date:  2021-01-07       Impact factor: 3.909

Review 6.  Improving radiation physics, tumor visualisation, and treatment quantification in radiotherapy with spectral or dual-energy CT.

Authors:  Matthijs Ferdinand Kruis
Journal:  J Appl Clin Med Phys       Date:  2021-11-07       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.